Clinical Trial Update: A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the effects of once-weekly Exenatide on glucose control and safety in Asian subjects with Type 2 Diabetes Mellitus has completed. Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2012-12-31